SITE MAP

25 years as an experienced pharma R&D leader and executive; CSO Agenus, former Roche Palo Alto president; CEO of Kinemed; President & CSO of Incyte; EVP of Research at DuPont-Merck.

CONTACT US

25 years of experience in mitochondrial disease pathophysiological mechanism, 10 years of experience in mitochondrial disease therapeutics.

David Ferrick

Ph.D.

Gino Cortopassi

(530) 304-6810

​gino@ixchelpharma.com

​gacortopassi@gmail.com

Gino Cortopassi

Ph.D. Biochemistry

Over 10 years of experience studying signal transduction of aging and metabolic disorders.

Scientist at Janssen Pharmaceutical, subsidiary of Johnson & Johnson. Over 15 years of R&D experience in preclinical drug discovery; former Roche Palo Alto research scientist in neuroscience and inflammation therapy areas.

Over 15 years of R&D experience in drug discovery, CSO Seahorse Bio, former senior management positions at Guava Technologies and Rigel Pharmaceuticals.

Sunil Sahdeo

Ph.D. Pharmacology and Toxicology

© 2017 Ixchel Pharma

Founding Members

Alexey Tomilov

Ph.D. Biochemistry

Advisory Board

Bob Stein

MD, Ph.D.